Aim Bulletin
Corero swings to loss despite improved order intake
Corero Network Security reported a 19% improvement in its first-half order intake on Thursday, reaching $13m.
Faron Pharmaceuticals names interim chief medical officer
Cancer immunotherapy-focussed biopharmaceutical firm Faron Pharmaceuticals named Dr Birge Berns as its interim chief medical officer on Thursday, with the transition becoming effective on 22 September, with Dr Berns operating from the UK.
Mercia Asset Management reports solid start to year
Mercia Asset Management reported a strong start to the financial year in an update on Thursday, with a consistent performance across its asset classes.
Filtronic wins $4.25m satellite communications contract
Aerospace, defence and space products manufacturer Filtronic announced a significant contract win with a top-tier global provider in the realm of low earth orbit (LEO) satellite communications equipment on Thursday.
Trakm8's new financial year begins as expected
Telematics and data technology specialist Trakm8 said in an update on Thursday that its financial year had begun as expected.
First-half losses narrow for 4basebio
Biotechnology company 4basebio reported revenues from its DNA and Hermes products surpassing £0. 2m in its first half on Thursday.
Alpha Group progressing plans for main market listing
Corporate financial solutions specialist Alpha Group International updated the market on its ambition to move to the premium list of the main market on Thursday.
CVS Group optimistic after year of growth
Veterinary service provider CVS Group reported a solid set of full-year financial results on Thursday, as revenues surged 9. 8% to £608. 3m.
Fonix Mobile reports robust set of full-year results
Fonix Mobile announced a robust set of full-year financial results on Thursday, with a 3. 7% rise in total payment volume to £268. 1m.
Shares in Strix slump on disappointing interim numbers
Shares in Strix Group plunged on Thursday, after the Aim-listed firm reported a slide in half-year profits.